2016 Endocrine Board Review Course

September 11, 2016 to September 12, 2016

Unlike other board preparation meetings, the Endocrine Society's Board Review Course offers a comprehensive mock-exam format, with case-based ABIM-style questions forming the bulk of the presentations. Each section follows the ABIM blueprint for the board exam, covering the breadth and depth of the certification/recertification examination. But you won't just get a right or wrong answer—each case will be discussed in detail, with the correct and incorrect answer options reviewed. You'll also have opportunities to ask questions directly to the faculty, and review detailed answer explanations, references, and a customized score report.

Target Audience

This continuing medical education activity should be of substantial interest to endocrinologists, internists, and endocrine fellows preparing for the board examination or recertification; or endocrinologists and other healthcare practitioners seeking a review in endocrinology.

Learning Objectives

Upon completion of this educational activity, learners will be able to demonstrate enhanced medical knowledge and clinical skills across all major areas of endocrinology; apply knowledge and skills in diagnosing, managing, and treating a wide spectrum of endocrine disorders; and successfully complete the board examination for certification or recertification in the subspecialty of endocrinology, diabetes, and metabolism.

Additional Information

Target Audience: 
Physician-in-practice
Fellow
Resident
Clinical researcher
Scientific researcher
Educator/Teacher
Pharmacist
Nurse/Nurse practitioner
Physician assistant
Allied health professional
Other
Competency Area: 
Professionalism
Patient Care and Procedural Skills
Medical Knowledge
Practice-based Learning and Improvement
Systems-based Practice
Topic Area: 
Adrenal/HPA Axis
Bone and Calciotropic Hormones
Diabetes and Glucose Metabolism
Lipid Disorders and Fatty Liver Diseases
General Endocrinology
Hormone Abuse
Growth Disorders
Health Disparities
Hormones and Cancer
Men’s Health
Neuroendocrinology and Pituitary
Nutrition
Obesity
Surgery
Thyroid/HPT Axis
Women’s Health
Level of Outcomes: 
Level 1 (Participation)
Level 2 (Satisfaction)
Level 3A (Learning: Declarative Knowledge (Knows))
Level 3B (Learning: Procedural Knowledge (Knows How))
Level 4 (Learning: Competence (Shows How))
Activity summary
Available credit: 
  • 14.50 ABIM MOC
  • 14.50 AMA PRA Category 1 Credits
  • 14.50 CME Certificate of Participation
Course opens: 
09/11/2016
Course expires: 
09/30/2017
Event starts: 
09/11/2016 - 8:00am
Event ends: 
09/12/2016 - 5:00pm
Rating: 
3.666665
Washington State Convention Center
Seattle, WA
United States

Endocrine Board Review Chair
David S. Cooper, MD – The Johns Hopkins University School of Medicine

Faculty Authors           
Richard J. Auchus, MD, PhD – University of Michigan
Carolyn B. Becker, MD – Brigham and Women’s Hospital
Rhonda M. Bentley-Lewis, MD, MMSc – Massachusetts General Hospital
Daniel H. Bessesen, MD – University of Colorado School of Medicine
Andrea D. Coviello, MD – Boston University School of Medicine
Serge A. Jabbour, MD – Thomas Jefferson University Sidney Kimmel Medical College
Mark E. Molitch, MD – Northwestern University Feinberg School of Medicine
Elizabeth N. Pearce, MD, MSc – Boston University School of Medicine
Margaret E. Wierman, MD – University of Colorado School of Medicine

Medical Editor  
Abbie L. Young, MS, CGC, ELS(D)

Disclosure Policy

The faculty, committee members, and staff who are in a position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The faculty reported the following relevant financial relationship(s) during the content development process for this activity:

Richard J. Auchus, MD, PhD: Contracted Research, Atterocor Therapeutics, Strongbridge Biopharma; Contracted Research & Consultant, Novartis Pharmaceuticals; Consultant, Bluebird Bio, Corcept Therapeutics, Innocrin Pharmaceuticals, Ipsen Pharmaceuticals, Janssen Pharmaceuticals, Pfizer, Inc., Tokai Pharmaceuticals; Scientific Advisory Board, Laboratory Corporation of America, Orphagen Pharmaceuticals

Rhonda M. Bentley-Lewis, MD, MMSc: Consultant, Merck & Co.; Research Support, Sanofi; Research Support (Spouse), Novartis Pharmaceuticals

Daniel H. Bessesen, MD: Data Safety Monitoring Board Member, Enteromedics Inc.

Andrea D. Coviello, MDSpeaker, Novo Nordisk Inc.

Serge A. Jabbour, MDConsultant, AstraZeneca, Eli Lilly & Co., Janssen Pharmaceuticals

Mark E. Molitch, MD: Consultant, Corcept, Eli Lilly & Co., Pfizer; Consultant and Investigator, Ipsen Pharmaceuticals, Novartis Pharmaceuticals, Novo Nordisk Inc.

The following faculty reported no relevant financial relationships: Carolyn B. Becker, MD, MBBS; David S. Cooper, MD; Elizabeth N. Pearce, MD, MSc; Margaret E. Wierman, MD

Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

Available Credit

  • 14.50 ABIM MOC
  • 14.50 AMA PRA Category 1 Credits
  • 14.50 CME Certificate of Participation

Accreditation Period

Course opens: 
09/11/2016
Course expires: 
09/30/2017